Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Pediatric Hypereosinophilia: Characteristics, Clinical Manifestations, and Diagnoses.

Burris D, Rosenberg CE, Schwartz JT, Zhang Y, Eby MD, Abonia JP, Fulkerson PC.

J Allergy Clin Immunol Pract. 2019 May 22. pii: S2213-2198(19)30466-0. doi: 10.1016/j.jaip.2019.05.011. [Epub ahead of print]

PMID:
31128377
2.

Prevalence of eosinophilic colitis and the diagnoses associated with colonic eosinophilia.

DiTommaso LA, Rosenberg CE, Eby MD, Tasco A, Collins MH, Lyles JL, Putnam PE, Mukkada VA, Rothenberg ME.

J Allergy Clin Immunol. 2019 May;143(5):1928-1930.e3. doi: 10.1016/j.jaci.2018.12.1002. Epub 2019 Jan 14. No abstract available.

PMID:
30654053
3.

Nationally Representative Readmission Factors Associated with Endovascular versus Open Repair of Abdominal Aortic Aneurysm.

Martinez R, Gaffney L, Parreco J, Eby M, Hayson A, Donath E, Bathaii M, Finch M, Zeltzer J.

Ann Vasc Surg. 2018 Nov;53:105-116. doi: 10.1016/j.avsg.2018.04.043. Epub 2018 Aug 7.

PMID:
30092423
4.

Alignment of parent- and child-reported outcomes and histology in eosinophilic esophagitis across multiple CEGIR sites.

Aceves SS, King E, Collins MH, Yang GY, Capocelli KE, Abonia JP, Atkins D, Bonis PA, Carpenter CL, Dellon ES, Eby MD, Falk GW, Gonsalves N, Gupta SK, Hirano I, Kocher K, Krischer JP, Leung J, Lipscomb J, Menard-Katcher P, Mukkada VA, Pan Z, Spergel JM, Sun Q, Wershil BK, Rothenberg ME, Furuta GT; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

J Allergy Clin Immunol. 2018 Jul;142(1):130-138.e1. doi: 10.1016/j.jaci.2018.05.014. Epub 2018 May 29.

PMID:
29852258
5.

Nationally Representative Readmission Factors in Patients with Claudication and Critical Limb Ischemia.

Martinez RA, Shnayder M, Parreco J, Gaffney L, Eby M, Cortolillo N, Lopez M, Zeltzer J.

Ann Vasc Surg. 2018 Oct;52:96-107. doi: 10.1016/j.avsg.2018.03.011. Epub 2018 May 17.

PMID:
29777842
6.

Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study.

Shoda T, Wen T, Aceves SS, Abonia JP, Atkins D, Bonis PA, Caldwell JM, Capocelli KE, Carpenter CL, Collins MH, Dellon ES, Eby MD, Gonsalves N, Gupta SK, Falk GW, Hirano I, Menard-Katcher P, Kuhl JT, Krischer JP, Leung J, Mukkada VA, Spergel JM, Trimarchi MP, Yang GY, Zimmermann N, Furuta GT, Rothenberg ME; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

Lancet Gastroenterol Hepatol. 2018 Jul;3(7):477-488. doi: 10.1016/S2468-1253(18)30096-7. Epub 2018 May 3.

PMID:
29730081
7.

A Tactical Medicine After-action Report of the San Bernardino Terrorist Incident.

Bobko JP, Sinha M, Chen D, Patterson S, Baldridge T, Eby M, Harris W, Starling R, Lichtman O.

West J Emerg Med. 2018 Mar;19(2):287-293. doi: 10.5811/westjem.2017.10.31374. Epub 2018 Feb 26. No abstract available.

8.

Eosinophilic esophagitis (EoE) genetic susceptibility is mediated by synergistic interactions between EoE-specific and general atopic disease loci.

Martin LJ, He H, Collins MH, Abonia JP, Biagini Myers JM, Eby M, Johansson H, Kottyan LC, Khurana Hershey GK, Rothenberg ME.

J Allergy Clin Immunol. 2018 May;141(5):1690-1698. doi: 10.1016/j.jaci.2017.09.046. Epub 2017 Nov 10.

9.

Comparison of online marketing techniques on food and beverage companies' websites in six countries.

Bragg MA, Eby M, Arshonsky J, Bragg A, Ogedegbe G.

Global Health. 2017 Oct 26;13(1):79. doi: 10.1186/s12992-017-0303-z.

10.

Deforestation Induced Climate Change: Effects of Spatial Scale.

Longobardi P, Montenegro A, Beltrami H, Eby M.

PLoS One. 2016 Apr 21;11(4):e0153357. doi: 10.1371/journal.pone.0153357. eCollection 2016.

11.

Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease.

Martin LJ, Franciosi JP, Collins MH, Abonia JP, Lee JJ, Hommel KA, Varni JW, Grotjan JT, Eby M, He H, Marsolo K, Putnam PE, Garza JM, Kaul A, Wen T, Rothenberg ME.

J Allergy Clin Immunol. 2015 Jun;135(6):1519-28.e8. doi: 10.1016/j.jaci.2015.03.004.

12.

Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis.

Alexander ES, Martin LJ, Collins MH, Kottyan LC, Sucharew H, He H, Mukkada VA, Succop PA, Abonia JP, Foote H, Eby MD, Grotjan TM, Greenler AJ, Dellon ES, Demain JG, Furuta GT, Gurian LE, Harley JB, Hopp RJ, Kagalwalla A, Kaul A, Nadeau KC, Noel RJ, Putnam PE, von Tiehl KF, Rothenberg ME.

J Allergy Clin Immunol. 2014 Nov;134(5):1084-1092.e1. doi: 10.1016/j.jaci.2014.07.021. Epub 2014 Sep 22.

13.

PedsQL eosinophilic esophagitis module: feasibility, reliability, and validity.

Franciosi JP, Hommel KA, Bendo CB, King EC, Collins MH, Eby MD, Marsolo K, Abonia JP, von Tiehl KF, Putnam PE, Greenler AJ, Greenberg AB, Bryson RA, Davis CM, Olive AP, Gupta SK, Erwin EA, Klinnert MD, Spergel JM, Denham JM, Furuta GT, Rothenberg ME, Varni JW.

J Pediatr Gastroenterol Nutr. 2013 Jul;57(1):57-66. doi: 10.1097/MPG.0b013e31828f1fd2.

14.

Auto-transfusion tourniquets: the next evolution of tourniquets.

Tang DH, Olesnicky BT, Eby MW, Heiskell LE.

Open Access Emerg Med. 2013 Dec 4;5:29-32. doi: 10.2147/OAEM.S39042. eCollection 2013. Review.

15.

Comment on "Climate sensitivity estimated from temperature reconstructions of the Last Glacial Maximum".

Fyke J, Eby M.

Science. 2012 Sep 14;337(6100):1294; author reply 1294. doi: 10.1126/science.1221371.

16.

MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers.

Lu TX, Sherrill JD, Wen T, Plassard AJ, Besse JA, Abonia JP, Franciosi JP, Putnam PE, Eby M, Martin LJ, Aronow BJ, Rothenberg ME.

J Allergy Clin Immunol. 2012 Apr;129(4):1064-75.e9. doi: 10.1016/j.jaci.2012.01.060. Epub 2012 Mar 3.

17.

Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.

Wertz IE, Kusam S, Lam C, Okamoto T, Sandoval W, Anderson DJ, Helgason E, Ernst JA, Eby M, Liu J, Belmont LD, Kaminker JS, O'Rourke KM, Pujara K, Kohli PB, Johnson AR, Chiu ML, Lill JR, Jackson PK, Fairbrother WJ, Seshagiri S, Ludlam MJ, Leong KG, Dueber EC, Maecker H, Huang DC, Dixit VM.

Nature. 2011 Mar 3;471(7336):110-4. doi: 10.1038/nature09779. Erratum in: Nature. 2011 Jul 7;475(7354):122.

PMID:
21368834
18.

Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome.

Widemann BC, Balis FM, Kim A, Boron M, Jayaprakash N, Shalabi A, O'Brien M, Eby M, Cole DE, Murphy RF, Fox E, Ivy P, Adamson PC.

J Clin Oncol. 2010 Sep 1;28(25):3979-86. doi: 10.1200/JCO.2009.25.4540. Epub 2010 Aug 2.

19.

The societal challenge of ocean acidification.

Turley C, Eby M, Ridgwell AJ, Schmidt DN, Findlay HS, Brownlee C, Riebesell U, Fabry VJ, Feely RA, Gattuso JP.

Mar Pollut Bull. 2010 Jun;60(6):787-92. doi: 10.1016/j.marpolbul.2010.05.006. No abstract available.

20.

Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation.

Jaiswal BS, Janakiraman V, Kljavin NM, Chaudhuri S, Stern HM, Wang W, Kan Z, Dbouk HA, Peters BA, Waring P, Dela Vega T, Kenski DM, Bowman KK, Lorenzo M, Li H, Wu J, Modrusan Z, Stinson J, Eby M, Yue P, Kaminker JS, de Sauvage FJ, Backer JM, Seshagiri S.

Cancer Cell. 2009 Dec 8;16(6):463-74. doi: 10.1016/j.ccr.2009.10.016.

21.

Setting cumulative emissions targets to reduce the risk of dangerous climate change.

Zickfeld K, Eby M, Matthews HD, Weaver AJ.

Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16129-34. doi: 10.1073/pnas.0805800106. Epub 2009 Aug 17.

22.

Comment on "Saturation of the southern ocean CO2 sink due to recent climate change".

Zickfeld K, Fyfe JC, Eby M, Weaver AJ.

Science. 2008 Feb 1;319(5863):570; author reply 570. doi: 10.1126/science.1146886.

23.

DUBA: a deubiquitinase that regulates type I interferon production.

Kayagaki N, Phung Q, Chan S, Chaudhari R, Quan C, O'Rourke KM, Eby M, Pietras E, Cheng G, Bazan JF, Zhang Z, Arnott D, Dixit VM.

Science. 2007 Dec 7;318(5856):1628-32. Epub 2007 Nov 8.

24.

pHUSH: a single vector system for conditional gene expression.

Gray DC, Hoeflich KP, Peng L, Gu Z, Gogineni A, Murray LJ, Eby M, Kljavin N, Seshagiri S, Cole MJ, Davis DP.

BMC Biotechnol. 2007 Sep 26;7:61.

25.

Regulation of ERK3/MAPK6 expression by BRAF.

Hoeflich KP, Eby MT, Forrest WF, Gray DC, Tien JY, Stern HM, Murray LJ, Davis DP, Modrusan Z, Seshagiri S.

Int J Oncol. 2006 Oct;29(4):839-49.

PMID:
16964379
26.

ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.

Dornan D, Shimizu H, Mah A, Dudhela T, Eby M, O'rourke K, Seshagiri S, Dixit VM.

Science. 2006 Aug 25;313(5790):1122-6.

27.

Oncogenic BRAF is required for tumor growth and maintenance in melanoma models.

Hoeflich KP, Gray DC, Eby MT, Tien JY, Wong L, Bower J, Gogineni A, Zha J, Cole MJ, Stern HM, Murray LJ, Davis DP, Seshagiri S.

Cancer Res. 2006 Jan 15;66(2):999-1006.

28.

Whose life is it anyway--the dying patient's or the nurse's?

Eby M.

Nurs Ethics. 2005 Mar;12(2):121-2. No abstract available.

PMID:
15791781
29.

Cell line cross-contamination: how aware are Mammalian cell culturists of the problem and how to monitor it?

Buehring GC, Eby EA, Eby MJ.

In Vitro Cell Dev Biol Anim. 2004 Jul-Aug;40(7):211-5.

PMID:
15638703
30.

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.

Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, Ma A, Koonin EV, Dixit VM.

Nature. 2004 Aug 5;430(7000):694-9. Epub 2004 Jul 18.

PMID:
15258597
31.

Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.

Zhou H, Wertz I, O'Rourke K, Ultsch M, Seshagiri S, Eby M, Xiao W, Dixit VM.

Nature. 2004 Jan 8;427(6970):167-71. Epub 2003 Dec 24.

PMID:
14695475
32.

Correspondence Nursing Management readers have their say.

Carey P, Eby M.

Nurs Manag (Harrow). 2003 Sep 1;10(5):6.

PMID:
27707067
33.

Eiger and its receptor, Wengen, comprise a TNF-like system in Drosophila.

Kauppila S, Maaty WS, Chen P, Tomar RS, Eby MT, Chapo J, Chew S, Rathore N, Zachariah S, Sinha SK, Abrams JM, Chaudhary PM.

Oncogene. 2003 Jul 31;22(31):4860-7.

PMID:
12894227
34.

Data protection: Part Two.

Eby M.

Nurs Manag (Harrow). 2003 Jul;10(4):35-7. Review. No abstract available.

PMID:
12868182
35.

Data protection: Part One.

Eby M.

Nurs Manag (Harrow). 2003 Jun;10(3):32-5. No abstract available.

PMID:
12830635
36.

Role of MRIT/cFLIP in protection against chemotherapy-induced apoptosis.

Matta H, Eby MT, Gazdar AF, Chaudhary PM.

Cancer Biol Ther. 2002 Nov-Dec;1(6):652-60.

PMID:
12642689
37.

Differential inactivation of caspase-8 in lung cancers.

Shivapurkar N, Toyooka S, Eby MT, Huang CX, Sathyanarayana UG, Cunningham HT, Reddy JL, Brambilla E, Takahashi T, Minna JD, Chaudhary PM, Gazdar AF.

Cancer Biol Ther. 2002 Jan-Feb;1(1):65-9.

PMID:
12170765
38.

The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex.

Liu L, Eby MT, Rathore N, Sinha SK, Kumar A, Chaudhary PM.

J Biol Chem. 2002 Apr 19;277(16):13745-51. Epub 2002 Feb 5.

39.
40.

Cytotoxicity of Tumor necrosis factor related apoptosis-inducing ligand towards Ewing's sarcoma cell lines.

Kumar A, Jasmin A, Eby MT, Chaudhary PM.

Oncogene. 2001 Feb 22;20(8):1010-4.

41.

Withdrawing or withholding artificial hydration and nutrition.

Eby MA.

Nurs Ethics. 2000 Sep;7(5):376-8. No abstract available.

PMID:
11221397
42.

The ectodermal dysplasia receptor activates the nuclear factor-kappaB, JNK, and cell death pathways and binds to ectodysplasin A.

Kumar A, Eby MT, Sinha S, Jasmin A, Chaudhary PM.

J Biol Chem. 2001 Jan 26;276(4):2668-77. Epub 2000 Oct 16.

43.

Activation of the NF-kappaB pathway by caspase 8 and its homologs.

Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, Hood L.

Oncogene. 2000 Sep 14;19(39):4451-60.

44.
45.

Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins.

Chaudhary PM, Jasmin A, Eby MT, Hood L.

Oncogene. 1999 Oct 14;18(42):5738-46.

46.
47.

Cloning and characterization of two Toll/Interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans.

Chaudhary PM, Ferguson C, Nguyen V, Nguyen O, Massa HF, Eby M, Jasmin A, Trask BJ, Hood L, Nelson PS.

Blood. 1998 Jun 1;91(11):4020-7.

48.

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway.

Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L.

Immunity. 1997 Dec;7(6):821-30.

49.

Ethical issues in nursing research: the wider picture.

Eby MA.

Nurse Res. 1995 Sep 1;3(1):5-13. doi: 10.7748/nr.3.1.5.s2.

PMID:
27284856
50.

Amendment No. 62 to the Education Bill, third reading, House of Lords, 6 July 1993.

Eby MA.

Nurs Ethics. 1994 Mar;1(1):63. No abstract available.

PMID:
7828059

Supplemental Content

Support Center